Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran.
Breast Cancer. 2022 Sep;29(5):899-907. doi: 10.1007/s12282-022-01372-y. Epub 2022 Jun 1.
Breast cancer is one of the most common cancers among women in the world. Different therapeutic strategies such as radiotherapy, chemotherapy and surgery have been used either individually or in combination. Oncolytic virotherapy is a rising treatment methodology, which utilizes replicating viruses to eliminate tumor cells. The aim of this study was to investigate the oncolytic activity of live-attenuated poliovirus in breast cancer cell lines.
The CD155 expression level in two human breast cancer cell lines and a normal breast cell line were evaluated using real-time PCR and flow cytometry. Virus titration was assessed by TCID50. The cytotoxicity of poliovirus on cell line and apoptosis response was investigated by MTT and Caspase 8 and Caspase 9 ELISA kits, respectively.
This study showed that CD155 gene was expressed significantly (p = 0.001) higher in both human breast cancer cell lines compared to the normal cell line. The protein expression level of CD155 was 98.1%, 96.7%, in MDA_MB231 and MCF_7 cell lines, respectively, whereas the CD155 expression level was 1.3% in MCF_10A. The cytopathic effect of poliovirus in breast cancer cell lines was significantly higher than normal cells (p < 0.05). Extrinsic apoptosis response was more effective than intrinsic apoptosis in both breast cancer cell lines (p < 0.05).
In summary, administration of live-attenuated poliovirus can be a promising treatment to breast cancer. However, in vitro and in vivo studies will be required to evaluate the safety of this strategy.
乳腺癌是全世界女性中最常见的癌症之一。放射治疗、化学疗法和手术等不同的治疗策略已经被单独或联合使用。溶瘤病毒治疗是一种新兴的治疗方法,它利用复制病毒来消除肿瘤细胞。本研究旨在研究活减毒脊髓灰质炎病毒在乳腺癌细胞系中的溶瘤活性。
使用实时 PCR 和流式细胞术评估两种人乳腺癌细胞系和一种正常乳腺细胞系中 CD155 的表达水平。通过 TCID50 评估病毒滴度。通过 MTT 和 Caspase 8 和 Caspase 9 ELISA 试剂盒分别研究脊髓灰质炎病毒对细胞系的细胞毒性和细胞凋亡反应。
本研究表明,与正常细胞系相比,两种人乳腺癌细胞系中 CD155 基因表达显著(p = 0.001)更高。MDA_MB231 和 MCF_7 细胞系中 CD155 的蛋白表达水平分别为 98.1%和 96.7%,而 MCF_10A 中的 CD155 表达水平为 1.3%。脊髓灰质炎病毒在乳腺癌细胞系中的细胞病变效应明显高于正常细胞(p < 0.05)。在两种乳腺癌细胞系中,外源性细胞凋亡反应比内源性细胞凋亡更有效(p < 0.05)。
总之,活减毒脊髓灰质炎病毒的给药可能是治疗乳腺癌的一种有前途的方法。然而,需要进行体外和体内研究来评估这种策略的安全性。